Pharmacovigilance, also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring and prevention of adverse effects with pharmaceutical products.
In accordance with the ethical principles of the company, the requirements of international legislation and for the fulfilment of the commitments undertaken to our customers, AMAXA has developed and implemented the robust Pharmacovigilance System.
We have developed and implemented standard operating procedures that govern the processes of identifying, collecting, recording and transmitting information to the competent authorities with regard to:
- lack of effectiveness of the medicine
- suspected adverse reactions when using medicines provided by AMAXA
Our senior pharmacovigilance officials regularly attend pharmacovigilance related training courses to keep ahead of new developments.
In the case of suspected adverse reactions or suspected lack of efficacy of medicine delivered by our company, please complete the form on the right.